General MedicationsOPHTHALMICStandard
CILOXAN
CIPROFLOXACIN HYDROCHLORIDE
Standard Dose
EQ 0.3% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CILOXAN is listed in Drugs@FDA under application 020369 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN HYDROCHLORIDE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE Sponsor SANDOZ Submission history Latest submission status date: 2017-02-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview CILOXAN is listed in Drugs@FDA under application 020369 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN HYDROCHLORIDE Form and strength OINTMENT;OPHTHALMIC - EQ 0.3% BASE Sponsor SANDOZ Submission history Latest submission status date: 2017-02-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.